Works matching IS 13524585 AND DT 2015 AND VI 21 AND IP 1

Results: 19

Editor’s Commentary.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 3, doi. 10.1177/1352458515569405

By:

Thompson, Alan;
Carroll, William;
Antel, Jack

Publication type:

Article

We can compare the relative efficacy multiple sclerosis medications by examining the results of independent clinical trials: Commentary.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 39, doi. 10.1177/1352458514564591

By:

Hutchinson, Michael

Publication type:

Article

The Charcot Lecture | Beating MS: A story of B cells, with twists and turns.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 8, doi. 10.1177/1352458514561911

By:

Hauser, Stephen L

Publication type:

Article

Reviewer List.

Published in:: Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 113, doi. 10.1177/1352458514560104
Publication type:: Article

We can compare the relative efficacy of multiple sclerosis medications by examining the results of independent clinical trials: No.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 37, doi. 10.1177/1352458514559866

By:

Ciccarelli, Olga;
Chataway, Jeremy

Publication type:

Article

We can compare the relative efficacy of multiple sclerosis medications by examining the results of independent clinical trials: Yes.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 35, doi. 10.1177/1352458514558678

By:

Dahdaleh, Dima;
Sharrack, Basil

Publication type:

Article

Female infertility and multiple sclerosis: Is this an issue?

Published in:

2015

By:

McCombe, Pamela A;
Stenager, Egon

Publication type:

Editorial

Alemtuzumab: A new therapy for active relapsing–remitting multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 22, doi. 10.1177/1352458514549398

By:

Hartung, Hans-Peter;
Aktas, Orhan;
Boyko, Alexey N

Publication type:

Article

Serum anti-Müllerian hormone levels in reproductive-age women with relapsing–remitting multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 41, doi. 10.1177/1352458514540843

By:

Thöne, Jan;
Kollar, Susanne;
Nousome, Darryl;
Ellrichmann, Gisa;
Kleiter, Ingo;
Gold, Ralf;
Hellwig, Kerstin

Publication type:

Article

Uveitis as a prognostic factor in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 105, doi. 10.1177/1352458514539782

By:

Shugaiv, Erkingul;
Tüzün, Erdem;
Kürtüncü, Murat;
Kıyat-Atamer, Aslı;
Çoban, Arzu;
Akman-Demir, Gulsen;
Tugal-Tutkun, Ilknur;
Eraksoy, Mefkure

Publication type:

Article

Falls in people with MS—an individual data meta-analysis from studies from Australia, Sweden, United Kingdom and the United States.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 92, doi. 10.1177/1352458514538884

By:

Nilsagård, Y;
Gunn, H;
Freeman, J;
Hoang, P;
Lord, S;
Mazumder, Rajarshi;
Cameron, Michelle

Publication type:

Article

The aetiology of acute neurological decline in multiple sclerosis: Experience from an open-access clinic.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 67, doi. 10.1177/1352458514538333

By:

Tallantyre, Emma C;
Causon, Emmie G;
Harding, Katharine E;
Pickersgill, Trevor P;
Robertson, Neil P

Publication type:

Article

Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing–remitting multiple sclerosis (RRMS).

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 57, doi. 10.1177/1352458514537013

By:

Gold, Ralf;
Giovannoni, Gavin;
Phillips, J Theodore;
Fox, Robert J;
Zhang, Annie;
Meltzer, Leslie;
Kurukulasuriya, Nuwan C

Publication type:

Article

Reduced information processing speed as primum movens for cognitive decline in MS.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 83, doi. 10.1177/1352458514537012

By:

Van Schependom, Jeroen;
D’hooghe, Marie B;
Cleynhens, Krista;
D’hooge, Mieke;
Haelewyck, Marie-Claire;
De Keyser, Jacques;
Nagels, Guy

Publication type:

Article

Depression in multiple sclerosis: A long-term longitudinal study.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 76, doi. 10.1177/1352458514536086

By:

Koch, Marcus W;
Patten, Scott;
Berzins, Sandy;
Zhornitsky, Simon;
Greenfield, Jamie;
Wall, Winona;
Metz, Luanne M

Publication type:

Article

Age-dependent effects on the treatment response of natalizumab in MS patients.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 48, doi. 10.1177/1352458514536085

By:

Matell, Henrik;
Lycke, Jan;
Svenningsson, Anders;
Holmén, Carolina;
Khademi, Mohsen;
Hillert, Jan;
Olsson, Tomas;
Piehl, Fredrik

Publication type:

Article

Multiple deep white matter lesions mimicking multiple sclerosis as an unusual complication of a left atrial myxoma.

Published in:

2015

By:

Negrotto, Laura

Publication type:

Opinion

Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxoma.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 108, doi. 10.1177/1352458514535677

By:

Quan, Chao;
ZhangBao, Jingzi;
Luo, Sushan;
Fang, Kun;
Xi, Jianying;
Du, Zunguo;
Zhao, Chongbo;
Lu, Jiahong

Publication type:

Article

Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials.

Published in:

Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 101, doi. 10.1177/1352458514533846

By:

Dong, Jing;
Zhao, Yinshan;
Petkau, A John;
Li, David KB;
Riddehough, Andrew;
Traboulsee, Anthony

Publication type:

Article